We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$664M
AUM Growth
+$25.7M
Cap. Flow
-$5.39M
Cap. Flow %
-0.81%
Top 10 Hldgs %
33.22%
Holding
147
New
22
Increased
60
Reduced
40
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 18.36%
2 Healthcare 13.1%
3 Consumer Staples 10.59%
4 Technology 10.39%
5 Consumer Discretionary 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUN icon
126
Sunoco
SUN
$14B
$235K 0.04%
4,725
XBI icon
127
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$233K 0.04%
+3,750
New +$214K
SLB icon
128
SLB Ltd
SLB
$76.5B
$231K 0.03%
2,710
-479
-15% -$44.1K
C icon
129
Citigroup
C
$223B
$230K 0.03%
4,250
+199
+5% +$10.6K
BAC icon
130
Bank of America
BAC
$436B
$229K 0.03%
+12,799
New +$219K
BMY icon
131
Bristol-Myers Squibb
BMY
$128B
$228K 0.03%
+3,866
New +$218K
UN
132
DELISTED
Unilever NV New York Registry Shares
UN
$228K 0.03%
5,842
-600
-9% -$23.5K
EPD icon
133
Enterprise Products Partners
EPD
$82.5B
$226K 0.03%
+6,264
New +$232K
LFCR icon
134
Lifecore Biomedical
LFCR
$163M
$216K 0.03%
+15,668
New +$202K
BP icon
135
BP
BP
$109B
$215K 0.03%
6,790
-117
-2% -$3.93K
ES icon
136
Eversource Energy
ES
$28.1B
$214K 0.03%
+4,000
New +$199K
COP icon
137
ConocoPhillips
COP
$141B
$213K 0.03%
3,087
+115
+4% +$8.03K
DUK icon
138
Duke Energy
DUK
$100B
$209K 0.03%
+2,506
New +$202K
ABBV icon
139
AbbVie
ABBV
$454B
$201K 0.03%
+3,074
New +$194K
OPK icon
140
Opko Health
OPK
$936M
$194K 0.03%
19,425
-575
-3% -$4.92K
AGEN
141
Agenus
AGEN
$255M
$190K 0.03%
2,442
CATX icon
142
Perspective Therapeutics
CATX
$322M
$58K 0.01%
3,948
CLNE icon
143
Clean Energy Fuels
CLNE
$432M
$56K 0.01%
11,200
AVEO
144
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$13K ﹤0.01%
+1,506
New +$13.8K
BGMD
145
DELISTED
BG MEDICINE INC COM STK NEW
BGMD
$11K ﹤0.01%
+6,201
New +$10.4K
BRKL
146
DELISTED
Brookline Bancorp
BRKL
-11,396
Closed -$97K
CTAS icon
147
Cintas
CTAS
$84.4B
-11,840
Closed -$209K

Similar funds

Crestwood Advisors Group's Q4 2014 Portfolio in Review

As of Q4 2014, Crestwood Advisors Group held 147 positions worth $664M, up 4% from $639M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Crestwood Advisors Group's Q4 2014 filing shows 22 new, 60 increased, 40 reduced and 2 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 30,152 shares worth $1.19M. The largest sale was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $19.8M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Crestwood Advisors Group's largest Q4 2014 buy was State Street Energy Select Sector SPDR ETF: 30,152 shares worth $1.19M.
  • Crestwood Advisors Group added most to Medtronic in Q4 2014, an estimated $8.8M increase.
  • Crestwood Advisors Group's biggest Q4 2014 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $19.8M.
  • Crestwood Advisors Group fully exited Cintas in Q4 2014, selling an estimated $209K.
  • Crestwood Advisors Group's ten largest holdings make up 33% of its $664M portfolio in Q4 2014.
  • Crestwood Advisors Group opened 22 new positions and closed 2 in Q4 2014.
  • Crestwood Advisors Group's portfolio value rose 4% quarter-over-quarter to $664M.

Based on Crestwood Advisors Group's 13F filing for Q4 2014, filed 18 Feb 2015.